GSK plc
Results of 23rd Annual General Meeting
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on Wednesday 3 May 2023 at the Sofitel Hotel in Terminal 5 Heathrow. Shareholders were able to join the meeting in person or virtually via the Lumi AGM website.
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 23 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 27 March 2023, which is available on GSK's website at www.gsk.com.
|
Resolution |
Total votes for(1)(2) |
% |
Total votes against(2) |
% |
Total votes cast |
Votes withheld(3) |
|
|
1 |
Receive and adopt the 2022 Annual Report |
2,838,286,554 |
99.05 |
27,282,840 |
0.95 |
2,865,569,394 |
11,463,434 |
|
2 |
Approve the Annual report on remuneration |
2,493,636,361 |
88.84 |
313,256,226 |
11.16 |
2,806,892,587 |
70,129,301 |
|
3 |
Election of Julie Brown |
2,857,379,637 |
99.59 |
11,814,146 |
0.41 |
2,869,193,783 |
7,831,272 |
|
4 |
Election of Dr Vishal Sikka |
2,860,647,976 |
99.69 |
8,837,033 |
0.31 |
2,869,485,009 |
7,534,298 |
|
5 |
Election of Elizabeth McKee Anderson |
2,744,478,188 |
95.64 |
125,073,699 |
4.36 |
2,869,551,887 |
7,475,279 |
|
6 |
Re-election of Sir Jonathan Symonds |
2,774,824,580 |
96.72 |
94,170,389 |
3.28 |
2,868,994,969 |
8,020,637 |
|
7 |
Re-election of Dame Emma Walmsley |
2,862,165,104 |
99.74 |
7,358,771 |
0.26 |
2,869,523,875 |
7,508,911 |
|
8 |
Re-election of Charles Bancroft |
2,786,237,098 |
97.24 |
79,167,334 |
2.76 |
2,865,404,432 |
11,602,033 |
|
9 |
Re-election of Dr Hal Barron |
2,845,192,710 |
99.17 |
23,938,850 |
0.83 |
2,869,131,560 |
7,896,993 |
|
10 |
Re-election of Dr Anne Beal |
2,788,179,755 |
97.17 |
81,326,824 |
2.83 |
2,869,506,579 |
7,517,274 |
|
11 |
Re-election of Dr Harry C Dietz |
2,863,558,514 |
99.83 |
4,932,171 |
0.17 |
2,868,490,685 |
8,534,053 |
|
12 |
Re-election of Dr Jesse Goodman |
2,863,346,622 |
99.79 |
6,079,498 |
0.21 |
2,869,426,120 |
7,596,197 |
|
13 |
Re-election of Urs Rohner |
2,627,550,485 |
91.58 |
241,613,171 |
8.42 |
2,869,163,656 |
7,856,370 |
|
14 |
Re-appointment of the auditor |
2,846,403,783 |
99.86 |
4,095,644 |
0.14 |
2,850,499,427 |
26,524,596 |
|
15 |
Remuneration of the auditor |
2,865,552,679 |
99.83 |
4,889,379 |
0.17 |
2,870,442,058 |
6,575,928 |
|
16 |
Approve amendments to the Directors' Remuneration Policy |
2,837,886,999 |
99.01 |
28,431,513 |
0.99 |
2,866,318,512 |
10,705,019 |
|
17 |
Authority for the company to make donations to political organisations and incur political expenditure |
2,778,351,786 |
98.69 |
36,846,645 |
1.31 |
2,815,198,431 |
61,881,372 |
|
18 |
Authority to allot shares |
2,749,592,663 |
95.85 |
118,984,091 |
4.15 |
2,868,576,754 |
8,438,938 |
|
19 |
Disapplication of pre-emption rights - general power(4) |
2,774,457,577 |
96.79 |
91,974,467 |
3.21 |
2,866,432,044 |
10,561,299 |
|
20 |
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4) |
2,747,347,831 |
95.84 |
119,258,296 |
4.16 |
2,866,606,127 |
10,393,035 |
|
21 |
Authority for the company to purchase its own shares(4) |
2,821,937,695 |
98.36 |
47,051,419 |
1.64 |
2,868,989,114 |
8,025,806 |
|
22 |
Exemption from statement of senior statutory auditor's name |
2,856,668,700 |
99.67 |
9,373,459 |
0.33 |
2,866,042,159 |
10,967,927 |
|
23 |
Authority for reduced notice of a general meeting other than an AGM(4) |
2,698,567,258 |
94.08 |
169,932,106 |
5.92 |
2,868,499,364 |
8,505,572 |
Notes:
(1) The "for" votes include those giving the Chair discretion.
(2) Votes "for" and "against" are expressed as a percentage of the total votes cast.
(3) A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.
(4) Indicates Special Resolutions requiring a 75% majority of votes cast.
The following table provides further information on participation in the AGM:
|
|
GSK's 23rd AGM (Hybrid meeting) (2023) |
GSK's 22nd AGM (Hybrid meeting) (2022) |
|
Issued share capital (excluding Treasury Shares) |
4,094,980,743 |
5,083,974,547 |
|
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) |
70.26% |
70.25% |
|
Total shareholder population |
63,362 |
89,764 |
|
Total number of proxies lodged |
3,162 |
5,343 |
|
Number of shareholders in attendance |
72 in person 49 participated virtually |
93 in person 68 participated virtually |
|
% of shareholders who lodged proxies |
4.99% |
5.95% |
The above poll results will shortly be available on the company's website at www.gsk.com.
In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's (FCA) Listing Rules, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the FCA and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
3 May 2023
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
